Dr. Thomas Michael Zizic is a Baltimore, Maryland based male rheumatologist who is specialized in Rheumatology. Active license number of Dr. Thomas Michael Zizic for Rheumatology is D0012471 in Maryland. Dr. Thomas Michael Zizic treat joint disease similar to orthopedists but do not perform surgeries. He diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Dr. Thomas Michael Zizic speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Rheumatology
Credentials:
M.D.
Gender:
Male
Practice Address:
5601 Loch Raven Blvd, Rmb Suite 509, Baltimore, Maryland, 21239-2905
Phone:
410-340-7819
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1609900109
NPI Enumeration Date:
15 Mar, 2007
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Thomas Michael Zizic are as mentioned below.
License Number
Specialization
State
Status
D0012471
Rheumatologist
Maryland
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
47 Loveton Cir Ste R, Sparks, Maryland
Zip:
21152-9216
Phone Number:
410-472-7203
Fax Number:
--
Patients can reach Dr. Thomas Michael Zizic at 5601 Loch Raven Blvd, Rmb Suite 509, Baltimore, Maryland or can call to book an appointment on 410-340-7819. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.